Nonbinding futility rule [Two-Stage / GS Designs]

posted by d_labes  – Berlin, Germany, 2018-06-13 18:59 (2532 d 10:25 ago) – Posting: # 18900
Views: 17,291

Dear Ben,

❝ General remark here: In your example we see that BE has not been achieved only marginally. The Repeated CI is (0.79215, 0.99993). Even though the power of stage 1 is large enough so that we formally conclude futility, one could question whether it is really a good idea to stop the trial due to futility ...


If I see it correctly that's called in Maurer et al. "futility rule can be applied in a nonbinding manner, ie, it can be used as guidance but must not necessarily be followed." (page 19, bottom)
How to obtain a sample size number for the second stage if we want to do so?

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,683 registered users;
100 visitors (0 registered, 100 guests [including 10 identified bots]).
Forum time: 05:24 CEST (Europe/Vienna)

There are two possible outcomes: if the result confirms the
hypothesis, then you’ve made a measurement. If the result is
contrary to the hypothesis, then you’ve made a discovery.    Enrico Fermi

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5